High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
650.00K
-59.65%
-0.410
-783.33%
3.00M
+22.75%
-0.320
-15.79%
500.00K
-43.44%
-0.460
-8%
Estimates Revision
The market is revising No Change the revenue expectations for Evogene Ltd. (EVGN) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -8.56%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-8.56%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Evogene Ltd (EVGN.O) is -0.94, compared to its 5-year average forward P/E of -2.09. For a more detailed relative valuation and DCF analysis to assess Evogene Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.09
Current PE
-0.94
Overvalued PE
-0.03
Undervalued PE
-4.16
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-0.56
Current EV/EBITDA
-1.59
Overvalued EV/EBITDA
0.24
Undervalued EV/EBITDA
-1.36
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
45.55
Current PS
3.60
Overvalued PS
141.86
Undervalued PS
-50.76
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
EVGN News & Events
Events Timeline
(ET)
2025-11-11
07:05:33
Evogene's Casterra and Fantini Reveal Strategic Partnership
2025-08-22 (ET)
2025-08-22
05:52:22
Evogene announces Q2 earnings per share of 10 cents, compared to a loss of 5 cents last year.
2025-08-19 (ET)
2025-08-19
07:06:04
Evogene announces Q2 continuing operations EPS of 50 cents compared to a loss of 85 cents last year.
Sign Up For More Events
Sign Up For More Events
News
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/cb162ac3885c4c41606ea21b547a894b09011c039f6aa896f3e54d9a590423db.png)
Preview
7.5
11-11PRnewswireCasterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/cover_image/81cb624dd0b29f98df1b0a8497884fbbfad74afc4a284cdef795e21762ba76ad.png)
Preview
9.5
11-06PRnewswireEvogene Schedules Third Quarter 2025 Financial Results Release
![[object Object]](https://d5bp8bijhhba2.cloudfront.net/image/default_image/newsfilter.png)
Preview
4.5
09-27NewsfilterEverGen Infrastructure Shares Updates on Operations and Development
Sign Up For More News
People Also Watch
FAQ
What is Evogene Ltd (EVGN) stock price today?
What is Evogene Ltd (EVGN)'s business?
What is the price predicton of EVGN Stock?
What is Evogene Ltd (EVGN)'s revenue for the last quarter?
What is Evogene Ltd (EVGN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Evogene Ltd (EVGN)'s fundamentals?
How many employees does Evogene Ltd (EVGN). have?